CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $680K of Cerevel Therapeutics Holdings, Inc.
Sold$680,071
$25.02Price
27,176Shares
−91%Stake
What CERE did after the filing
- The stock from Thu, Nov 9 close, $23.95
- +74.9%
- S&P 500, same days
- +9.6%
Measured over 30 trading days, to the Dec 22 close.
Traded Tue, Nov 7. Filed Thu, Nov 9, 12:03 PM ET, during the session. Returns use the Nov 9 close and the Dec 22 close. Not investment advice.